Small-Molecule Inhibitors and Degraders Targeting KRAS-Driven Cancers

Drug resistance continues to be a major problem associated with cancer treatment. One of the primary causes of anticancer drug resistance is the frequently mutated RAS gene. In particular, considerable efforts have been made to treat KRAS-induced cancers by directly and indirectly controlling the ac...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Soonsil Hyun, Dongyun Shin
Format: article
Langue:EN
Publié: MDPI AG 2021
Sujets:
RAS
Accès en ligne:https://doaj.org/article/69812bda3185416abd49d119a6d7fd35
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!